Review
Open access
Aug 2026
Regulatory Evolution and Transformation of China's Cell and Gene Therapy Industry
The Regulation on the Administration of Clinical Research and Clinical Translational Application of New Biomedical Technologies, which entered into force in 2026, is interpreted, with a particular focus on its new dual-track regulatory framework that comprises a drug registration pathway and a new biomedical technology...
Wei Li, Zhen Qin, Xiu'e Wang et al.
· Cytotherapy and Longevity · 0 citations